Chris Lewis

Chris Lewis is Tech Insider's Senior Equity Research analyst covering Internet and Interactive Entertainment. Prior to joining TI in 2011, Chris spent six years at Baird Capital having established the company’s Internet and Video Game research practice. Prior to Wall Street, Chris was a business analyst developing software at Chubb Corporation, and was a co-founder and CFO of Latin American career services website Detacuche.com. Chris appears frequently in the financial and industry press, including CNBC, Bloomberg, CNN, Wall Street Journal, and Financial Times, among others.

Consumer Goods Most Active Stocks: Tesla Motors Inc (NASDAQ:TSLA), Ford Motor (NYSE:F), General Motors (NYSE:GM), The Coca-Cola Company (NYSE:KO)

Tesla Motors Inc (NASDAQ:TSLA) has announced on its blog the launch of a leasing program for business owners. Tesla Motors Inc (NASDAQ:TSLA) promises customers will have to read and sign only three pages of agreements, written in plain language. The company also says clients will be able to handle and sign their lease contracts completely…

Read More

DRug Active runners: Pfizer Inc. (NYSE:PFE), Sanofi SA (ADR) (NYSE:SNY), AbbVie Inc (NYSE:ABBV), Johnson & Johnson (NYSE:JNJ)

Three years after Pfizer Inc. (NYSE:PFE) dropped a bombshell on its plans to lay off more than 1000 workers. The biopharmaceutical company has come back with some of the best news, on how it plans to use the vacated Groton site. In a joint announcement, Gov. Dannel P. Malloy and Pfizer confirmed that two buildings…

Read More

Consumer Goods Active runners: Apple Inc. (NASDAQ:AAPL), Ford Motor Company (NYSE:F), General Motors Company (NYSE:GM), The Coca-Cola Company (NYSE:KO)

Apple Inc. (NASDAQ:AAPL)’s iPhone 5S is still in the lead. A note from Cannacord Genuity analyst T. Michael Walkley showed Apple’s latest phone holds the number one position at all four major phone carriers. Apple Inc. (NASDAQ:AAPL) stock performance was -0.69% in last session and finished the day at $538.79. Traded volume was 5.81million shares…

Read More

Biotech New Lows: Recro Pharma (NASDAQ:REPH), Ruthigen (NASDAQ:RTGN), Mediwound (NASDAQ:MDWD), Dicerna Pharmaceuticals (NASDAQ:DRNA)

On March 12, 2014, Recro Pharma, Inc (NASDAQ:REPH) completed its initial public offering (“IPO”). In relation to such IPO, the Company filed information reflected in a slide presentation as a free writing prospectus on February 13, 2014. Recro Pharma Inc (NASDAQ:REPH) stock performance was -4.64% in last session and finished the day at $6.98. Traded…

Read More

Stocks Touched New Lows: Zoetis Inc (NYSE:ZTS), Coldwater Creek Inc. (NASDAQ:CWTR), Antares Pharma Inc (NASDAQ:ATRS), Outdoor Inc (NYSE:CBSO)

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (EDT) on Tuesday, May 6, 2014. Chief Executive Officer Juan Ramón Alaix and Executive Vice President and Chief Financial Officer Rick Passov will review first quarter 2014 financial results and respond to questions from financial analysts during the call. Zoetis Inc (NYSE:ZTS)…

Read More